FDA Issues Warning about Invokana

Posted on June 3, 2015

Recently, the U.S. Food and Drug Administration (FDA) has issued a public health advisory concerning a SGLT2 inhibitor diabetes drug, Johnson & Johnson’s Invokana. According to the warning, the drugs have been connected with ketoacidosis, a condition which can cause organ failure or death through excessive levels of acid in the bloodstream, as well as heart attacks and stroke.

This is not the first time the drug Invokana has been associated with health risks. On May 21, the Institute for Safe Medication Practices (ISMP) released a report on Invokana’s connection with kidney failure.

The FDA action was sparked by a string of ketoacidosis cases associated with SGLT2 inhibitor use between March 2013 and June 6, 2014. The patients, all of whom were treated in an emergency room or at a hospital, were atypical cases: the condition is more commonly associated with type 1 diabetes – the patients had type 2 diabetes and their blood sugar levels were only slightly elevated.

If you have taken Invokana and exhibit the following symptoms, then you should discontinue use of the medication and seek immediate medical attention:

  • Difficulty breathing
  • Nausea or vomiting
  • Abdominal pain
  • Confusion
  • Fatigue

Also, reach out to the experienced Florida pharmaceutical litigation attorneys at Farah & Farah for reliable legal counsel. You may be entitled to compensation for the damages you have sustained as a result of Invokana use, including medical bills, lost wages during recovery, pain and suffering, and more. Call us today at (904) 549-6434 to learn more about your rights and legal options in a free consultation.

  • This field is for validation purposes and should be left unchanged.